Back to mobile site

Gilead Sciences (GILD) PT Raised to $164 at BofA Securities

October 12, 2026 6:17 AM EDT Send to a Friend
BofA Securities analyst Tazeen Ahmad raised the price target on Gilead Sciences (NASDAQ: GILD) to $164.00 (from $162.00) while maintaining ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login